Stephanie Decollogne

Stephanie Decollogne has extensive experience in oncology research and preclinical development, with roles at Nanobiotix as Director of Global NonClinical Development and Senior Manager in Preclinical Toxicology. Stephanie also worked as a Preclinical Program Leader at UNSW, overseeing research projects for new anti-cancer drug candidates. Stephanie has managed preclinical departments, collaborated with multidisciplinary teams, and coordinated projects in academic and pharmaceutical settings throughout their career.

Stephanie Decollogne completed their Master's Degree at Université Paris Cité from 1985 to 1990. Stephanie then pursued a Master's Degree in Pharmacology at Paris-Sud University (Paris XI) from 1990 to 1991, followed by a Doctor of Philosophy (Ph.D.) in Pharmacology at the same institution from 1991 to 1994. Finally, they obtained a MMedSc in Pharmaceutical Science Drug Development from UNSW from 2008 to 2010.